Duncan-Williams Maintains Buy on Wright Medical Group

Duncan-Williams is out with its report today on Wright Medical Group WMGI, maintaining Buy. In a note to clients, Duncan-Williams writes, "We are maintaining our BUY rating and our twelve month price target of $18.50. This represents approximately 20 times our 2011 adjusted EPS estimate of $0.94. WMGI currently trades at approximately 1.19 times 2011 revenue." Shares of WMGI closed Thursday at $14.80.